ùÛÚ¸ ¾ç±¹ ¾àÇÐÀÇ ¹Ì·¡¸¦ ¹àÈú ¿¬±¸Áø°ú ÀþÀº ¾àÇеµµéÀÌ ÃֽŠ¿¬±¸Áö°ßÀ» °øÀ¯ÇÏ°í ¹ßÀü½ÃÅ°´Â Á¶ÀÎÆ®¼¼¹Ì³ª¸¦ ÁøÇàÇß´Ù.
À̹ø ¼¼¹Ì³ª´Â ‘±ÔÁ¦°úÇÐ ºÐ¾ß¿¡¼ ÀÓ»ó½ÃÇè Çõ½Å’À̶ó´Â ÁÖÁ¦·Î ¼º±Õ°ü´ë ¹ÙÀÌ¿ÀÇコ ±ÔÁ¦°úÇаú ¹× Á¦¾à»ê¾÷Çаú¿Í ¹Ì±¹ USC(University of Southern California) ´ëÇÐ ¿¬±¸ÁøÀÌ ÆгΠÅäÀÇ ¹× ÀÚÀ¯Åä·ÐÀ» ³ª´³À¸¸ç À¯À¯Á¦¾à À¯¿ø»ó ´ëÇ¥À̻簡 ¸ð´õ·¹ÀÌÅÍ·Î ÁøÇàÀ» ¸Ã¾Ò´Ù.
¼¼¹Ì³ª ÁÖ¿ä ÁÖÁ¦·Î ¹Ì±¹Ò® ÀÓ»ó½ÃÇè °ü·Ã ÃֽŠÀ̽´, ±¹³» RWD ±ÔÁ¦ °¡À̵å¶óÀÎ ¹× Ç×¾ÏÁ¦ ºÐ¾ß¿¡¼ ¿ÜºÎ´ëÁ¶±º È°¿ë»ç·Ê¸¦ ºñ·ÔÇØ Current Trends in Patient-Centered Trials in oncology, Emulation of RCTs with RWD: NOACs in Patients with VTE µîÀ» ¹ßÇ¥Çß´Ù.
À̹ø ¼¼¹Ì³ª¸¦ ÅëÇØ ÇÑ¹Ì ¾ç±¹ ÀÓ»ó½ÃÇè µ¿Çâ ¹× ±ÔÁ¦°úÇÐ °üÁ¡¿¡¼ ÀÓ»ó½ÃÇè Çõ½Å¿¡ ´ëÇØ ½Éµµ ±íÀº ³íÀÇ°¡ ÁøÇàµÆÀ¸¸ç, ÇâÈÄ °øµ¿¿¬±¸ ¼öÇà µî ¿¬±¸±³·ù¸¦ ¹ßÀü½Ãų ¼ö ÀÖ´Â °è±â°¡ µÇ¾ú´Ù.
ÇÑÆí À̹ø Á¶ÀÎÆ®¼¼¹Ì³ª¿¡ Âü¿©ÇÑ USC ´ëÇÐ ¿¬±¸Áø ¹× ¹Ú»ç °úÁ¤ ´ëÇпø»ýµéÀº À¯À¯Á¦¾àÀ» ¹æ¹®ÇØ ¾àÇÐ ±ÔÁ¦ ÇöȲ¿¡ ´ëÇØ À¯À¯Á¦¾à R&D Àη°ú Åä·Ð ¹× ¹ßÇ¥¸¦ ÁøÇàÇÒ ¿¹Á¤ÀÌ´Ù. USC´ëÇÐ Eunjoo Pacifici ±³¼ö´Â À¯À¯Á¦¾à ½Å¾à¿¬±¸ÀÚ¹®À§¿øÀ¸·Î ÀǾàÇ° Çã°¡ ¹× µî·Ï Regulatory Advisor ¿ªÇÒÀ» ¼öÇàÇÏ°í ÀÖ´Ù.
±è»ç¶û ±âÀÚ kimsarang0420
<ÀúÀÛ±ÇÀÚ © ÆʽºÅ¹, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>